Macrogenics (MGNX) – Business Wire
-
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies
-
Cullinan Oncology Completes $98.5 Million Series B Financing
-
Notice of Lead Plaintiff Deadline for Shareholders in the Macrogenics, Inc. Securities Class Action Lawsuit
Back to MGNX Stock Lookup